Skip to main content
. 2022 Apr 19;66(2):229–236. doi: 10.20945/2359-3997000000457

Table 2. Distribution of the variables under study for 2 separate groups considering the diagnosis of CD.

CD diagnosis
Without CD (n = 90) With CD (n = 4) Statistics p Effect size
Gender, n (%) Fisher 1,000 Φ = 0,01
Female 47 (52,2%) 2 (50,0%)
Male 43 (47,8%) 2 (50,0%)
Age at T1D diagnosis (years) t(92) = −1,550 1,000 d = 0,01
Mean 5,85 7,88
SD/Min-Max 2,56/1,08-10.42) 2,23/5,67-10,75
PH of AID, n (%) Fisher 1,000 Φ = 0,38
No 87 (96,7%) 4 (100%)
Yes 3 (3,3%) 0 (0%)
FH of AID, n (%) Fisher 0,104 Φ = 0,21
No 78 (86,7%) 2 (50%)
Yes 12 (13,3%) 2 (50%)
HLA screening, n (%) Fisher 1,000 Φ = 0,11
Negative 8 (16,3%) 0 (0%)
Positive 41 (83,7%) 3 (100)
CD antibodies, n (%) Fisher 0,001 * Φ = 1,00
Negative 90 (100%) 0 (0%)
Positive 0 (0%) 4 (100%)
*

P < 0.05;

Φ = Phi; Cohen's d - d.